Ontrak (OTRK) Competitors $1.57 +0.01 (+0.58%) As of 11:24 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesSEC FilingsShort InterestTrendsBuy This Stock OTRK vs. BNR, MRAI, ENZ, BRTX, MGRX, SSY, BGLC, ACON, DHAC, and VSEEShould you be buying Ontrak stock or one of its competitors? The main competitors of Ontrak include Burning Rock Biotech (BNR), Marpai (MRAI), Enzo Biochem (ENZ), BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), BioNexus Gene Lab (BGLC), Aclarion (ACON), Digital Health Acquisition (DHAC), and Vsee Health (VSEE). These companies are all part of the "healthcare" industry. Ontrak vs. Burning Rock Biotech Marpai Enzo Biochem BioRestorative Therapies Mangoceuticals SunLink Health Systems BioNexus Gene Lab Aclarion Digital Health Acquisition Vsee Health Burning Rock Biotech (NASDAQ:BNR) and Ontrak (NASDAQ:OTRK) are both small-cap business services companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, media sentiment, earnings, community ranking, institutional ownership, risk, profitability and valuation. Which has more volatility and risk, BNR or OTRK? Burning Rock Biotech has a beta of 0.72, meaning that its stock price is 28% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.3, meaning that its stock price is 130% more volatile than the S&P 500. Does the MarketBeat Community favor BNR or OTRK? Ontrak received 33 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 59.38% of users gave Ontrak an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote. CompanyUnderperformOutperformBurning Rock BiotechOutperform Votes531.25% Underperform Votes1168.75% OntrakOutperform Votes3859.38% Underperform Votes2640.63% Do institutionals and insiders believe in BNR or OTRK? 30.0% of Burning Rock Biotech shares are owned by institutional investors. Comparatively, 12.9% of Ontrak shares are owned by institutional investors. 30.3% of Burning Rock Biotech shares are owned by insiders. Comparatively, 1.9% of Ontrak shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is BNR or OTRK more profitable? Burning Rock Biotech has a net margin of -83.50% compared to Ontrak's net margin of -237.77%. Burning Rock Biotech's return on equity of -60.68% beat Ontrak's return on equity.Company Net Margins Return on Equity Return on Assets Burning Rock Biotech-83.50% -60.68% -42.30% Ontrak -237.77%-171.34%-113.42% Do analysts rate BNR or OTRK? Ontrak has a consensus price target of $45.00, indicating a potential upside of 2,784.62%. Given Ontrak's stronger consensus rating and higher probable upside, analysts plainly believe Ontrak is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Ontrak 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer BNR or OTRK? In the previous week, Ontrak had 5 more articles in the media than Burning Rock Biotech. MarketBeat recorded 5 mentions for Ontrak and 0 mentions for Burning Rock Biotech. Burning Rock Biotech's average media sentiment score of 0.00 beat Ontrak's score of -0.29 indicating that Burning Rock Biotech is being referred to more favorably in the media. Company Overall Sentiment Burning Rock Biotech Neutral Ontrak Neutral Which has better valuation & earnings, BNR or OTRK? Ontrak has lower revenue, but higher earnings than Burning Rock Biotech. Burning Rock Biotech is trading at a lower price-to-earnings ratio than Ontrak, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBurning Rock Biotech$515.82M0.06-$92.07M-$1.88-1.65Ontrak$10.85M0.61-$27.92M-$15.81-0.10 SummaryOntrak beats Burning Rock Biotech on 10 of the 18 factors compared between the two stocks. Get Ontrak News Delivered to You Automatically Sign up to receive the latest news and ratings for OTRK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OTRK vs. The Competition Export to ExcelMetricOntrakhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.58M$2.06B$5.37B$8.39BDividend YieldN/A6.99%5.22%4.10%P/E Ratio-0.1516.0626.8419.71Price / Sales0.613.40392.34117.39Price / CashN/A9.3238.2534.62Price / Book0.283.966.794.50Net Income-$27.92M$87.49M$3.23B$248.18M7 Day Performance-9.51%-7.77%4.07%1.14%1 Month Performance8.33%-4.21%12.52%15.20%1 Year Performance-61.19%-29.28%16.83%6.56% Ontrak Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OTRKOntrak2.5265 of 5 stars$1.57+0.6%$45.00+2,768.1%-61.2%$6.56M$10.85M-0.15250News CoverageEarnings ReportGap UpBNRBurning Rock Biotech0.4426 of 5 stars$2.46+5.6%N/A-59.2%$25.20M$515.82M-0.821,390Upcoming EarningsMRAIMarpaiN/A$1.34+3.1%N/A-34.0%$19.96M$34.87M-0.51150ENZEnzo BiochemN/A$0.33-14.8%N/A-69.0%$17.03M$29.09M0.00520Gap DownHigh Trading VolumeBRTXBioRestorative Therapies3.3258 of 5 stars$1.85+2.8%$18.00+873.0%+23.0%$13.88M$401,000.00-1.217Analyst RevisionGap DownMGRXMangoceuticals0.1827 of 5 stars$1.72-2.0%N/A-98.7%$8.89M$615,873.00-0.303Earnings ReportSSYSunLink Health SystemsN/A$0.89-2.6%N/A+42.5%$6.27M$31.23M6.361,376News CoverageAnalyst ForecastGap UpBGLCBioNexus Gene Lab0.2595 of 5 stars$3.07+15.0%N/A-44.9%$5.52M$9.51M0.0030Negative NewsEarnings ReportACONAclarion1.6392 of 5 stars$7.60+7.0%$11,758.50+154,617.1%-99.8%$4.42M$45,724.000.007Positive NewsEarnings ReportDHACDigital Health AcquisitionN/A$1.17-3.3%N/A-91.4%$4.22MN/A0.002,021VSEEVsee Health1.1856 of 5 stars$1.15-2.1%$5.00+336.7%N/A$4.13M$6.38M0.00N/AGap Up Related Companies and Tools Related Companies BNR Competitors MRAI Competitors ENZ Competitors BRTX Competitors MGRX Competitors SSY Competitors BGLC Competitors ACON Competitors DHAC Competitors VSEE Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OTRK) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ontrak, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ontrak With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.